Guidelines for the determination of brain death in infants and children: An update of the 1987 Task Force recommendations

OBJECTIVE:To review and revise the 1987 pediatric brain death guidelines. METHODS:Relevant literature was reviewed. Recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. CONCLUSIONS AND RECOMMENDATIONS:1) Determination of brain dea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2011-09, Vol.39 (9), p.2139-2155
Hauptverfasser: Nakagawa, Thomas A, Ashwal, Stephen, Mathur, Mudit, Mysore, Mohan R, Bruce, Derek, Conway, Edward E, Duthie, Susan E, Hamrick, Shannon, Harrison, Rick, Kline, Andrea M, Lebovitz, Daniel J, Madden, Maureen A, Montgomery, Vicki L, Perlman, Jeffrey M, Rollins, Nancy, Shemie, Sam D, Vohra, Amit, Williams-Phillips, Jacqueline A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVE:To review and revise the 1987 pediatric brain death guidelines. METHODS:Relevant literature was reviewed. Recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. CONCLUSIONS AND RECOMMENDATIONS:1) Determination of brain death in term newborns, infants, and children is a clinical diagnosis based on the absence of neurologic function with a known irreversible cause of coma. Because of insufficient data in the literature, recommendations for preterm infants 30 days to 18 yrs) is recommended. The first examination determines the child has met the accepted neurologic examination criteria for brain death. The second examination confirms brain death based on an unchanged and irreversible condition. Assessment of neurologic function after cardiopulmonary resuscitation or other severe acute brain injuries should be deferred for ≥24 hrs if there are concerns or inconsistencies in the examination. 4) Apnea testing to support the diagnosis of brain death must be performed safely and requires documentation of an arterial Paco2 20 mm Hg above the baseline and ≥60 mm Hg with no respiratory effort during the testing period. If the apnea test cannot be safely completed, an ancillary study should be performed. 5) Ancillary studies (electroencephalogram and radionuclide cerebral blood flow) are not required to establish brain death and are not a substitute for the neurologic examination. Ancillary studies may be used to assist the clinician in making the diagnosis of brain death a) when components of the examination or apnea testing cannot be completed safely as a result of the underlying medical condition of the patient; b) if there is uncertainty about the results of the neurologic examination; c) if a medicati
ISSN:0090-3493
1530-0293
DOI:10.1097/CCM.0b013e31821f0d4f